Weekly Investment Analysts’ Ratings Changes for Henry Schein (HSIC)

Henry Schein (NASDAQ: HSIC) recently received a number of ratings updates from brokerages and research firms:

• 8/9/2026 – Henry Schein was downgraded by Wall Street Zen from “buy” to “hold”.
• 8/6/2026 – Henry Schein had its “overweight” rating reaffirmed by Barclays PLC. They now have a $100.00 price target on the stock, up from $86.00.
• 8/5/2026 – Henry Schein was given a new $104.00 price target by Barrington Research.
• 8/5/2026 – Henry Schein was given a new $94.00 price target by UBS Group AG. They now have a “neutral” rating on the stock.
• 8/5/2026 – Henry Schein was given a new $95.00 price target by Stifel Nicolaus.
• 8/5/2026 – Henry Schein had its “buy” rating reaffirmed by Citigroup Inc.. They now have a $112.00 price target on the stock, up from $100.00.
• 8/5/2026 – Henry Schein had its “buy” rating reaffirmed by BTIG Research. They now have a $100.00 price target on the stock.
• 8/1/2026 – Henry Schein was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/31/2026 – Henry Schein had its “hold (c+)” rating reaffirmed by Weiss Ratings.
• 7/29/2026 – Henry Schein had its price target raised by Piper Sandler from $91.00 to $95.00. They now have an “overweight” rating on the stock.
• 7/28/2026 – Henry Schein had its “neutral” rating reaffirmed by UBS Group AG. They now have a $89.00 price target on the stock, up from $85.00.
• 7/12/2026 – Henry Schein was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/8/2026 – Henry Schein is now covered by BMO Capital Markets. They set a “market perform” rating and a $85.00 price target on the stock.
• 7/8/2026 – Henry Schein was upgraded by BMO Capital Markets to “hold”.

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.